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INTRODUCTION 
 
Amyotrophic lateral sclerosis (ALS), also known as Lou Gerhrig’s disease, is a progressive 
neurodegenerative disorder that currently holds the worst prognosis of this class of neurological 
disorders. The name may sound familiar due to the famous Ice Bucket Challenge that began four 
years ago with the goal to raise money and awareness for this devastating disease. Because of 
the rapid nature of this progression, the average survival time from the onset of symptoms is only 
3-5 years, giving it the worst prognosis of the neurodegenerative disorders. Stephen Hawking is 
a famous anomaly, having survived over fifty years with the disease. However, this is sadly not 
the case for most patients. Only about 5% of cases survive over 20 years with ALS. Although 
other disorders such as Alzheimer’s Disease or Parkinson’s Disease are more prevalent in our 
society, it is important to also draw attention to ALS which currently has no cure and few 
effective treatments.  
 
The disease is primarily characterized by degeneration of the upper and lower motor 
neurons which innervate muscles controlling voluntary movements (Chio et al., 2009). When 
these motor neurons degenerate, nerve cells can no longer provide nourishment to the muscle 
cells and the muscles begin to atrophy or become weaker and smaller. This disease targets the 
lateral regions of the spinal cord and results in sclerosis or hardening of those regions as the 
disease progresses. Voluntary muscles are those which are under conscious control. This means 
that muscles in the arms or legs can be affected, but the heart and digestive system will not be. 
However, swallowing and breathing is controlled by voluntary muscles and will become 
progressively more difficult as the disease advances. Weakening of the diaphragm muscle will 
leave the patient unable to breathe, making respiratory failure the most common cause of death 
in ALS patients (Wolf et al., 2017).  
 
Nearly all cases of ALS occur sporadically, making this fatal disease even more difficult 
to treat. About 5-10% of cases have been found to be familial, with links to heritable mutations 
in a diverse range of proteins (Machamer et al., 2014). Therapies related to its pathogenesis 
remain elusive, with the greatest advances being made in provision of care and supportive care, 
such as nutrition and respiratory support (Morgan et al, 2016). Disease-modifying treatment is 
limited to Riluzole, a glutamatergic antagonist used to block the release of glutamate from nerve 
cells, ultimately reducing the glutamate-induced deterioration of neurons. This drug is the only 
known treatment which extends the life of a patient, with about a 36% reduction in mortality 
(Fang et al., 2018). Although it has been effective at slowing the disease progression in some 
cases, it only focuses on treating the symptoms, rather than the causes. This highlights the need 
for identifying the underlying mechanisms responsible for maintenance of the synapses of these 
affected motor neurons. This knowledge is crucial for understanding the basis of early neuronal 
defects in aging and neurodegenerative diseases.  
 
Abnormal intracellular protein aggregates are commonly found in neurodegenerative 
diseases. A few key proteins have been identified as being involved in the pathogenesis of ALS, 
including TAR DNA-binding protein 43 (TDP-43) and fused in sarcoma (FUS) (Mackenzie et 
al, 2010). These disease-related proteins share both functional and structural similarities and are 
both DNA/RNA binding proteins. Their cytoplasmic accumulation has been linked to 
neurodegeneration, although the mechanism behind this accumulation is still unknown. There 
are currently more than 35 ALS-linked mutations identified in TDP-43, and 30 ALS-linked 
mutations reported in FUS. This indicates that these proteins are promising candidates for 
developing biomarker assays and targeted therapies for patients with ALS (Mackenzie et al., 
2010). Acquiring these biomarkers could be used to more effectively screen and diagnose 
patients, evaluate their risk for developing the disorder, and to eventually create drug therapies 
targeted specifically for these individuals (Hottstein et al., 2017).  
 
In instances where ALS is found to be genetically inherited, mutations in the FUS-encoding 
gene have been found responsible for approximately 3% to 5% of cases (Sama et al., 2014). 
Normally, the wildtype FUS protein is a highly conserved nucleic-acid binding protein found 
predominantly in the cell nucleus. It is involved in a variety of cellular functions including DNA 
damage repair, RNA processing and cellular stress response, among others (Sama et al., 2014). 
All of these functions make this protein critical to the transcriptional and translational processes 
of the cell. FUS mutants, on the other hand, can cause irreversible protein aggregates associated 
with the pathogenesis of ALS.  
 
In terms of its role in the pathology of ALS, it is unclear whether disease-related mutations 
cause the loss of normal FUS function or instead induce the protein to acquire a gain of toxic 
function (Sama et al., 2014). Similar to TDP-43, FUS-related ALS pathology is characterized by 
mislocalization of FUS to the cytoplasm, resulting in a loss of its nuclear expression (Ishigashi 
et al., 2018). Previous studies on Drosophila and zebrafish have found that the functional loss of 
FUS results in neuronal cell death (Wang et al., 2011). On the other hand, accumulation of FUS 
in the cytoplasm has been strongly associated with stress granules, which are typically induced 
by various cellular stresses, such as oxidative stress or mitochondrial dysfunction that inhibit the 
initiation of protein translation. The presence of stress granules supports the gain of toxicity 
hypothesis of FUS-related pathology (Ishigashi et al., 2018). Based on the current body of 
knowledge, there are two possible mechanisms for which FUS could contribute to ALS 
pathology.  
 
With these hypotheses in mind, we turn to model organism Drosophila to help us better 
understand the synaptic defects underlying ALS pathogenesis. The fundamental mechanisms and 
morphology of neuromuscular junctions (NMJs), where motor neurons synapse onto muscle fibers, 
in Drosophila are well-conserved from fly to man. Additionally, studies have found that flies 
contain functional orthologs for nearly 75% of known human disease genes (LLoyd & Taylor, 
2017). This makes Drosophila an ideal model organism to study neuromuscular development and 
degeneration. These flies contain a human homolog of the FUS protein, known as the Cabeza (caz) 
gene. Caz is a member of the RNA binding proteins that are conserved from flies to humans. We 
hypothesize that since loss of FUS function may contribute to neuronal death, selectively knocking 
down caz in flies may tell us more about the pathogenesis of ALS.  
 
Most current research on ALS using a Drosophila model is performed during the larval 
stage of development. However, Drosophila are holometabolous, undergoing a remodeling of their 
muscle system when transitioning from the larval to adult stage during metamorphosis (Veverytsa 
et al., 2013). During this time, some neurons are either removed or restructured, and new neurons 
are integrated. The result is the generation of an adult specific neural circuit, which is responsible 
for behaviors such as copulation and flight (Veverytsa et al., 2013). Developing ALS early in life 
is extremely rare, with the average age of onset being 60 years, and most patients being diagnosed 
between ages 50 and 74 (Traxinger et al., 2013). A study found that altering electrical activity and 
cell adhesion molecule FasciclinII levels affected development at the adult abdominal NMJ in 
ways that are distinct from their larval and adult thoracic counterparts (Hebbar et al., 2006). 
Therefore, it is unclear if the results found in larval flies will mimic those found in the adult stage. 
We aim to fill this knowledge gap by assessing adult NMJs in transgenic flies containing ALS-
related genes.  
At this time, most research studying muscular development in Drosophila has targeted the 
indirect flight muscles (IFMs). These muscles share many features with vertebrate somatic muscle 
cells, which has made them excellent models for examining the genes involved in myogenesis, the 
development of muscle tissue (Gunage et al., 2017). Although the IFMs have a behavioral flight 
assay to assess their integrity, we chose to focus on the NMJs found in abdominal muscles, which 
are very similar in structure to larval NMJs. Many presynaptic and postsynaptic markers can be 
used in this tissue, making them a great model to analyze the synaptic integrity of the NMJs in 
transgenic flies. The NMJs are very visible in the abdominal tissue, with terminal boutons that 
form in a beads‐on‐a‐string arrangement that is easy to visualize and assess under a microscope 
(Pons et al., 2017). We hope that this abdominal model will help us answer the questions that 
remain unanswered about the pathogenesis of neurodegeneration in ALS.  
Given the existing body of knowledge on this disease, our goal is to detect the genes 
responsible for maintaining synaptic structure and function and clarify their roles in 
neuroprotection in vivo. This field currently lacks a genetically traceable model for assessing how 
synaptic maintenance occurs in aging and in neurodegenerative diseases such as ALS. There is a 
limited amount of knowledge on how the structure of the synapse becomes altered with age. Using 
the UAS-Gal4 system, the FUS gene can be driven in Drosophila for tissue-specific expression. 
We hypothesize  that abnormalities in synaptic maintenance underlie the mechanism behind 
neuronal loss in neurodegenerative diseases. We propose that targeting these early defects could 
prevent neuronal death, thereby addressing the root of the disease rather than simply treating its 
symptoms. Using wildtype flies as a baseline, synaptic markers can be expressed in the FUS gene 
model at various time points to determine early synaptic defects that relate to neurodegeneration 
in ALS. We hope that these results will help develop biomarkers critical to early detection and 
treatment for this disease.  
 
 
 
Figure 1: The ventral abdominal muscles and their innervation in adult Drosophila. (A) In wild type flies, 
the VAMs are organized in a stereotyped pattern on the abdomen as observed at low magnification. 
Muscles are labeled using a phalloidin staining. The white dotted line represents the ventral midline. (A’–
A”’) At higher magnification, motor neurons innervate each muscle fiber and synaptic boutons are 
visible. Adapted from Pons et al., 2017.  
 
Previous research on the ventral abdominal motor neurons was important to consider 
before beginning our experiments. The abdominal muscles in wild type flies have a stereotyped 
pattern containing 4 muscles labeled A2-A5, with each segment containing two hemisegments, as 
seen in Figure 1. The A2 segment is noted by the chevron pattern due to the presence of two 
chordotonal organs, which separate the two hemisegments (Pons et al., 2017). This was an 
important structural feature which helped us navigate the orientation of our tissue when observing 
it under a microscope. 
 
  
Figure 2: Age-dependent changes in synaptic active zones at the fly abdominal neuromuscular junction 
(NMJ).  Adapted from López-Arias et al., 2017.  
 
The larval NMJ has been successfully used to study the molecular bases of synaptic 
formation and physiology in Drosophila. Figure 2 illustrates the age-dependent changes in the 
number of active zones present at synapses. In the NMJ of wild type adult flies, there is a 
progressive increase in the number of active zones during the first two weeks of life. Afterwards, 
the active zones decrease. This transition from synapse addition to synapse elimination 
corresponds with the onset of fly behavioral and synaptic senescence (López-Arias et al., 2017).  
 
 Figure 3: “Dying back” model of motor neuron degeneration in ALS. Adapted from Krakora et al., 2012.  
Previous studies have suggested a “dying back” mechanism to explain the nature of the 
degeneration of motor neurons in ALS, as seen in Figure 3. Dying back involves the slow evolving 
distal to proximal axonal degeneration commonly observed in a wide variety of degenerative and 
toxic conditions of the central and peripheral nervous system (Dadon-Nachum et al., 2010) 
(Fischer et al. 2003). As the NMJs degenerate, the axons begin to slowly pull away as the motor 
neuron eventually degenerates, resulting in atrophy of the muscle fiber.  
 
 
 
 
RESULTS 
 
RNAi knockdown of Caz demonstrates age-dependent motor neuron degeneration in 
VAMNs.  
 
Figure 4: Age-dependent motor neuron degeneration in RNAi knockdown of Caz using a VAMN-specific 
driver.  
 
Our goal was to determine if knocking down Caz using RNAi and expressing the tissue-
specific knockdown would lead to motor neuron degeneration. This would help us better 
understand the effects of the loss of FUS in humans, to determine if it is involved in the early 
pathology of ALS. We examined the phenotypic differences in the motor neurons using a VAMN-
specific driver when knocking down Caz. When examining the HRP staining, we observed that 
the motor neurons in which Caz was knocked down seemed to contain a reduced number of visible 
boutons. The Phalloidin staining of the muscle tissue displayed no significant damage, indicating 
that the cell death was exclusive to the motor neurons. This indicates that the loss of FUS function 
in humans may lead to enhanced degeneration of the motor neurons at the synaptic level.  
 
 
Abdominal motor neurons show decreased expression of postsynaptic DLG when 
overexpressing wild type and mutant FUS.  
 
 
Figure 5: Abdominal motor neurons show decreased number and size of boutons when overexpressing 
mutant FUS-R521C, compared to control expressing gene reporter Luciferase (II).  
 
We next used the TSGal80 system to drive the expression of FUS wild type and mutant 
R521C, as well as our gene reporter control on the 2nd chromosome. We collected and aged 
females at 29°C, the temperature at which the FUS gene is turned on and can be expressed within 
the ventral abdominal motor neurons. We then compared the structural differences between the 
wild type and mutant FUS to assess their effects on the structural integrity of the synapse. DLG is 
a postsynaptic marker found at the subsynaptic reticulum in both larval and adult Drosophila. 
Previous studies have found that mutations in DLG alter the expression of DLG and cause 
significant changes in the structure of the subsynaptic reticulum at those synapses. The results 
indicate that DLG is required for normal synaptic structure and offer insights into the role of its 
homologs in maintaining vertebrate synapses (Lahey et al., 2015).  
The goal of staining for DLG was to better assess the integrity of the synapse in transgenic 
flies after aging. We observed decreased DLG expression in both wild type and mutant FUS 
compared to our control. However, the DLG was most visibly reduced in the mutant, suggesting 
that FUS overexpression could contribute to the loss of this vital protein. Expressing wild type 
FUS may have its own toxic effects since it is not endogenous to the flies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Characterizing our control using gene reporter TdTomato (III) in an age-dependent manner.  
 
We decided upon this gene reporter as a control for our experiments because it maintained 
synaptic integrity similar to wildtype flies. For this experiment, we did not utilize the TSGal80 
system. Instead, they were collected and raised in a 28.7°C. The goal was to examine the flies at 
several time points to assess any morphological changes that occur. Although we imaged segments 
A3-A5, we decided to narrow our focus to segment A3. We stained for DLG protein again to assess 
the synaptic integrity in aged flies. We noticed an apparent increase in DLG expression at age 21 
compared to age 5, and then another decrease at age 25. This is consistent with the expression 
pattern of the TdTomato gene reporter used and the HRP staining of the motor neurons. The 
phalloidin staining looks consistent between tissues, indicating that there was no muscular tissue 
damage to the preps.  
 
A previous study examined how aging affects the synaptic ultrastructure in the adult 
Drosophila NMJ using fluorescence and electron microscopy. The morphological changes they 
observed included increased bouton sizes with proportionally rising number of active zones (AZs) 
and increased synaptic vesicle density at AZs is increased in aged flies. Their findings suggest that 
aging is possibly accompanied by impaired synaptic vesicle release and recycling and a potentially 
compensatory expansion of AZs and postsynaptic densities (Wagner, 2015). These observations 
were important to consider when comparing our results. It is possible that the increased expression 
of our reporter in aged flies is due to an expansion of AZs at the synaptic level. To further 
characterize these age-dependent synaptic changes in the VAMNs, we stained for a series of 
synaptic markers in wild type flies to get an understanding of the baseline levels of their 
expression.  
 
Staining for presence/absence of synaptic markers to analyze their baseline expression 
levels in wild type flies.  
 
 
Table 1: Common antibodies used to assess synaptic structure at the NMJ. Adapted from Dr. Daniel 
Babcock and Jess Sidisky.  
 
 
 
 
Figure 7: Staining for presence/absence of synaptic markers to analyze integrity of aging synapse.  Alpha 
Spectrin -1:200, DLG-1:50, BRP-1:50, CSP-1:50, Neuroglian 1:25, Syntaxin 1:50, FAS II-1:100, Futsch-
1:200, GluRIII-1:2500, Synapsin 1:50, as seen in Table 1.  
 
Prior to analyzing these synaptic markers in the FUS/ caz model of ALS, we examined 
them in wild type flies. The synaptic markers chosen are commonly used to assess the structure of 
NMJ’s. The goal of this experiment was to characterize the synaptic density of several synaptic 
markers on the abdominal NMJ’s in wild type flies. These flies were collected and aged at 28.7°C 
for 14 days.  
 
Alpha spectrin is typically associated with the plasma membrane and functions in a 
lipoprotein pathway that delivers dietary fat to the larval fat body for storage (FlyBase). Our 
imaging displays alpha spectrin localization primarily on the axon of the motor neurons that does 
not extend towards the boutons. Boutons are defined as oval-shaped structures that contain 
multiple AZs where neurotransmitters are released, and each of these is apposed to a glutamate 
receptor (GluR) cluster (Menon et al., 2013). We can see in our images that the glutamate receptor 
IIc (GluRIII) is localized at the postsynaptic boutons of the motor neurons, as expected. The 
presynaptic bouton is surrounded by the subsynaptic reticulum (SSR) that contains 
neurotransmitter receptors, scaffolding proteins, and postsynaptic signaling complexes. DLG is a 
postsynaptic marker found in the subsynaptic reticulum. It is seen wrapping around the boutons, 
which is consistent with its known function. Bruchpilot (BRP) molecules form an elongated 
conformation that stretches from the AZ membrane towards the boutons, forming the well-
characterized T-bar structure at the NMJs (Ackerman et al., 2015). BRP is essential for enabling 
Ca2+ channels to cluster beneath the T-bar at the center of the AZ, which brings the Ca+2 source 
close and allows Ca+2 to fuse into the presynaptic membrane (Ackerman et al., 2015). BRP’s 
localization allows us to visualize the active zones in each bouton, which could be used in future 
experiments to characterize the levels of AZs in ALS transgenes.  
 
Cysteine string protein (CSP) and synapsin are both components of synaptic vesicles and 
are seen to localize around the boutons in a similar fashion. CSP is critical for neurotransmitter 
release at the NMJ of Drosophila, with previous studies showing it is also required for nerve 
terminal growth and the prevention of neurodegeneration in Drosophila and mice (Dawson-Scully 
et al., 2007). Synapsin is important for vesicle clustering, neurodevelopment, and plasticity (Vasin 
et al., 2014). Syntaxin is a T-SNARE transmembrane protein that drives membrane fusion during 
neurotransmitter release (Harris et al., 2016). It is also seen localized near the boutons, as expected.  
 
Neuroglian is a cell adhesion molecule that has been shown to be required for synaptic 
stability (Enneking et al., 2013). It is imaged along the entire length of the axon. We find Fascicillin 
II localized in a similar way in our images. FasII is another cell adhesion molecule which has been 
found to play a role in the stabilization of motor neuron branches during pruning in Drosophila 
flight muscles (Hebbar et al., 2005). Futsch is a component in synaptic microtubules that has been 
found to control synaptic growth at the Drosophila NMJ by regulating the synaptic microtubule 
cytoskeleton (Roos et al, 2000).  
 
Each of these postsynaptic markers could lead to deficits in neuronal integrity, making 
them a crucial component of our study. Once we characterized what these proteins look like in the 
adult Drosophila NMJ, we were able to begin characterizing them in flies expressing gene reporter 
Luciferase (III) or the wild type or mutant FUS gene. At the NMJ, studies have found that 
overexpressing either wild-type or mutant FUS reduced the number of active zones at the 
presynaptic terminal. Additionally, the postsynaptic terminal’s glutamate receptor subunit 
composition was altered, ultimately reducing the amount of neurotransmitters released (Machamer 
et al., 2014). They also found that motor neurons expressing mutant FUS-R521C resulted in 
decreased size of postsynaptic density and decreased number of synapses per unit area in mice 
(Qui et al., 2014).  We expanded on these results by staining for several synaptic markers and 
examining their density at ages 5, 14, 21, 25 and 28 in both wild type and mutant FUS. Although 
these results have not been imaged, they are a vital step forward towards discovering the synaptic 
defects underlying motor neuron degeneration in ALS.  
  
 
Discussion 
Overall, we’ve gained a greater understanding of the development of adult Drosophila 
NMJs, which are still not well characterized in this field. By aging them to different time points, 
we can better understand the characteristics of an aging motor neuron. Our transgenic crosses have 
given us a better understanding of the role that FUS protein overexpression and knockout of its fly 
homolog Cabeza plays in neuronal development. Although we were not able to image the synaptic 
markers in these transgenic flies, our characterization of their localization in wild type flies has 
broadened our knowledge on the abdominal NMJs as a whole.  
 
To further our experiments, we planned to begin to quantify the AZs in the boutons using 
synaptic marker BRP. We were able to stain for these markers in our control, wild type and mutant 
FUS flies. Quantifying the AZs would allow us to determine if there are structural differences that 
we cannot observe through simply looking at the confocal images. Perhaps there is a significant 
decrease in the localization of a vital synaptic marker that is initiating cell death in these motor 
neurons. As mentioned in our results, each synaptic marker analyzed has been found to play a 
crucial role to the integrity of the synapse and aberrations in their functions could lead to 
neurodegeneration. If we observe abnormalities in one or more synaptic markers, this will allow 
us to move forward and discover the genetic defect underlying these changes.  
  
We could expand on our results using the fly homolog Cabeza using the FLP/FRT system 
to knockdown the caz gene more specifically, rather than using the RNAi method that has known 
limitations. Cell-type-specific knock-down by transgenic RNAi typically displays a significant 
knockdown of only ~50-80%, which increases the risk of off-target effects in our flies. The 
FLP/FRT system will increase the efficacy of the knockdown, yielding more precise results.  
 
Despite our study, we are still left with many questions regarding the pathogenesis of ALS 
at the synaptic level. Moving forward, we could analyze the quantal content and size of the vesicles 
using electrophysiological methods. This will allow us to understand if ALS mutations are 
affecting the amount of neurotransmitter produced or released, giving us insight into how the motor 
neurons are starting to deteriorate. We could continue to explore the role of the loss of function or 
gain-of-toxic function of FUS in early synaptic defects to determine a genetic marker of the 
disease. Overall, our results help the scientific community gain more insight into detect the genes 
responsible for maintaining synaptic structure and function. The goal is to one day clarify their 
neuroprotective roles in hopes of developing a therapeutic treatment that will address the neuronal 
defects before the motor neurons even begin to die. Early intervention could potentially save many 
lives of those who have the potential to develop the symptoms of this fatal disease.  
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
Fly rearing and genetics 
GAL4 protein activates transcription through binding to upstream activation sequence (UAS), 
whereas GAL80 protein prevents GAL4-dependent transcription. The temperature-sensitive 
GAL80[ts] provides a temporal regulation of UAS transgene (Duffy, 2002).  
Flies were raised on standard Drosophila medium at 25°C. For aging experiments, adult flies were 
stored at 18°C and collected each day and raised at 29°C. The following fly stocks were obtained 
from the Bloomington Drosophila Stock Center: Oregon-R, UAS-FUS-HA, UAS-FUS-R521C, 
UAS-CAZ- RNAi, UAS-Luciferase (II), UAS-Luciferase (III), UAS-TdTomato (II), UAS-TdTomato 
(III), UAS- Luciferase-RNAi (II).  
 
Ventral Abdominal Dissection Procedure (adapted from Dr. Daniel Babcock)  
Flies were anesthetized with CO2 and dunked in 70 % ethanol, to reduce waxy coating. 4% 
Paraformaldehyde Fix was prepared in PBS. A 6cm sylgard dish was used. Tools used: 
Dissection scissors, 1 non-sharp pin forceps, 2 fine tipped forceps. In each dish we prepared 3 
preps as follows: a) Added PBS (room temperature) to the dish and removed wings. b) Next, 
used the scissors to cut at the distal end of the halters, removing the thorax, legs and head. 
Removed the genitalia next. Bisected the tissue along the dorsal midline of the abdominal 
segment. Next, pinned each corner of the tissue into the siligard dish. Used fine forceps to 
remove viscera (organs). Repeated for additional preps. Placed in Fix solution for 30 minutes at 
room temp. After 30 minutes, removed Fix and washed dish 3X with PBS. Discarded waste in 
the waste container under fume hood. 
Immunohistochemistry  
Following dissection, tissue was placed in 1.5 mL (1500µL) Blocking Buffer (BB) solution in 
the fridge (4⁰) for 1 hour. Primary antibodies (Fig.7) were diluted in BB and placed in 4⁰ fridge 
overnight. The tissue was then washed 4x with 1.5mL PBS with 0.3% Triton solution (PBST). 
Secondary antibody staining was applied and spun for 2 hours in a dark box at room temperature. 
The following secondary antibodies were used: 568 goat-α-mouse (1:200), 568 goat-α-rabbit 
(1:200), 488 HRP (1:200), 647 phalloidin (1:1000). Once secondary staining was complete, 
tissue was washed 4x with 1.5mL PBST (5 mins each). The tissue was then mounted onto a slide 
using Vectashield.  
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